Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Protein kinase C inhibitors for treatment of uveal melanoma

Protein kinase C inhibitors for treatment of uveal melanoma

US Patent 11413284 · Granted Aug 16, 2022

Estimated economic value: $39,265,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptors and uses thereof2025
Protein kinase C inhibitors for treatment of uveal melanoma2025
Protein kinase C inhibitors for treatment of uveal melanoma2025
Protein kinase C inhibitors for treatment of uveal melanoma2025
Protein kinase C inhibitors for treatment of uveal melanoma2025
Protein kinase C inhibitors for treatment of uveal melanoma2025
Combination therapy2024
Therapeutic combinations comprising a c-RAF inhibitor2024
Substituted pyrazolopyrimidines and substituted purines and their use as ubiquit2023
Protein kinase C inhibitors and methods of their use2022
Substituted pyrazolopyrimidines and substituted purines and their use as ubiquit2022
Combination therapy2022